Celltrion teams up with another Korean biopharma in antibody discovery deal
Two Korean companies have signed a joint R&D discovery agreement, with the potential to earn in the nine-figures.
Clinical-stage biopharma Genuv has partnered up with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
